If putting up pictures of these “football legends” beside the players’ tunnel wasn’t enough - A Brazilian journalist has now reported how their portraits were even displayed bigger than the players in the posters of India v/s Brazil match in Kolkata tomorrow 🤣
@gemsofbabus_ Apne constituency ke apne hi obligation wali ek pavement maintained rakh di.
“””Wowww bhai ab iska udhaar mai use 4 baar PM bana ke hi chuka sakta hu !”””
@LukaD0nut Looks like a good stat to serve to the son whose mother is probably on a death bed with top line govt medical facilities
Probably hand them a Diya to light aswell
It’s not like anyone’s dying
@gemsofbabus_ 3000 children die in India every month due to hunger or causes related to improper food availability
But birthday of a dictator is more important
The most expensive part of a hospital bill may never touch the hospital at all.
A patient admitted for care has no way of knowing whether the price on a medical consumable reflects its actual cost or a markup fixed long before it ever reached the ward. That gap in information is, at its core, a public health issue.
A survey of hospital consumables in Maharashtra found an IV infusion set with a trade price of ₹11.05 carrying a printed MRP of ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter procured at ₹29.41 carried an MRP of ₹310.
These are not elective purchases. Patients cannot compare prices, seek alternatives, or question a number printed on a box while receiving care and the MRP itself is often fixed upstream by manufacturers and distributors, disconnected from the trade price by a wide, unexplained margin. The result is a system where the party bearing the cost has the least information to evaluate it.
The regulatory gap is structural: scheduled medicines are capped under the Drugs (Prices Control) Order, 2013. Most medical devices and consumables are not leaving both the pricing and the information around it almost entirely unmonitored.
A review of these findings and clear guidelines on the permissible gap between trade procurement price and declared MRP have been recommended to the Department of Pharmaceuticals and the NPPA ; a step toward closing not just a pricing gap, but the information gap patients are left to bear alone.
#PublicHealth #GoodGovernance #Leadership #TukaramMundhe
https://t.co/Ye9CVzr8qU